drugset / Trial / NCT00375128
Sporozoite Challenge of Polyprotein Vaccinees
Phase 1/2
Completed
26 enrolled
European Vaccine Initiative
University of Oxford · collabWalter Reed Army Institute of Research (WRAIR) · collabWellcome Trust · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This study examines the ability of two new malaria vaccines (FP9-PP and MVA-PP) to prevent the development of malaria infection after controlled exposure to the parasite. Volunteers for this trial will have received these vaccines in the preceding trial VAC027.1.
Timeline
- Start
- 2006-09
- Primary completion
- —
- Completion
- 2007-04